نتائج البحث 41-50 من 2491 لعملية البحث عن Inhibition
... inhibitor). Cell Saver During Tumor Resection. Rochester, Minn. The aims of this study are to investigate the presence of tumor cells after filtration of ...
This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and requiring salvage therapy as assessed ...
This phase I trial is looking to see if sargramostim given with a nebulizer, in combination with standard immune checkpoint inhibitor therapy with nivolumab can ...
... inhibitor). Genomic and Proteomic Analyses of Aggressive Tumors. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is ...
Monoamine oxidase inhibitors (MAOIs): Pharmacology, administration, safety, and side effects. https://www.uptodate.com/contents/search. Accessed Dec. 29 ...
The Standard of Care options are: an EGFR tyrosine kinase inhibitor (erlotinib [TARCEVA®]), gemcitabine or vinorelbine (NAVELBINE®). A Study to ...
... inhibitor, crizotinib. After enrollment, patients will receive one cycle of Induction chemotherapy. Subsequent therapy will be based upon MIBG avidity and ...
To evaluate the incidence of immune checkpoint inhibitors (ICI)-induced colitis (IIC) ... Probiotics Preventing Immune Checkpoint Inhibitor-Induced Colitis.
Pharmacogenetics of selective serotonin reuptake inhibitors (SSRIs): A serotonin reuptake transporter (SERT)-based approach. Neurochemistry International ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.